Among the families who lost children and other loved ones in the nation’s opioid crisis, many had held out hope of someday facing OxyContin maker Purdue Pharma and its owners in a courtroom.
That prospect all but vanished Wednesday after a bankruptcy judge conditionally approved a settlement worth an estimated $10 billion. It was a deal that left many of those families feeling they didn’t get what they really wanted.
Create a display name to comment
This name will appear with your comment
